Sentynl Therapeutics Announces FDA Acceptance of CUTX-101 NDA Resubmission
Edwards Lifesciences Corp · ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES · Now $88.16
+5.7% since the alert
$83.38 → $88.16
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS